Last $19.47 USD
Change Today +0.05 / 0.26%
Volume 95.1K
GTIV On Other Exchanges
Symbol
Exchange
Berlin
NASDAQ GS
As of 8:10 PM 10/24/14 All times are local (Market data is delayed by at least 15 minutes).

gentiva health services (GTIV) Key Developments

Gentiva Health Services Inc., Kindred Healthcare Inc. - M&A Call

To discuss the pending transaction (definitive merger agreement)

Gentiva Health Services Inc.(NasdaqGS:GTIV) added to S&P Health Care Services Select Industry Index

Gentiva Health Services Inc.(NasdaqGS:GTIV) added to S&P Health Care Services Select Industry Index

Gentiva Health Services Inc. Announces Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended June 30, 2014; Revised Earnings Guidance for the Year 2014

Gentiva Health Services Inc. announced unaudited consolidated earnings results for the second quarter and six months ended June 30, 2014. For the quarter, the company reported net revenues of $498,040,000, income before income taxes of $16,898,000 and net income attributable to the company of $10,011,000 or $0.27 per basic and diluted share against net revenues of $414,424,000, income before income taxes of $11,392,000 and net income attributable to the company of $6,347,000 or $0.20 per basic and diluted share for the same period a year ago. Adjusted EBITDA was $54,301,000 against $39,014,000 a year ago. EBITDA was $47,955,000 against $38,270,000 a year ago. Adjusted net income attributable to the company was $13,934,000 or $0.38 per diluted share against net income attributable to the company of $6,799,000 or $0.22 per diluted share a year ago. For the second quarter of 2014, net cash provided by operating activities was $50.4 million, compared to $30.7 million in the prior year period. Free cash flow increased 83% to $47.5 million for the second quarter of 2014, compared to $25.9 million in the prior year period. Capital expenditures for the second quarter were $2.9 million. For the six months, the company reported net revenues of $985,545,000, income before income taxes of $17,917,000 and net income attributable to the company of $10,497,000 or $0.28 per diluted share against net revenues of $830,015,000, loss before income taxes of $201,080,000 and net loss attributable to the company of $200,830,000 or $6.51 per diluted share for the same period a year ago. Net cash provided by operating activities was $32,634,000 against $10,166,000 for the same period a year ago. Purchase of fixed assets was $6,032,000 against $7,521,000 for the same period a year ago. Adjusted EBITDA was $93,278,000 against $78,077,000 a year ago. EBITDA was $79,819,000 against LBITDA of $147,128,000 a year ago. Adjusted net income attributable to the company was $18,733,000 or $0.51 per diluted share against net income attributable to the company of $13,906,000 or $0.45 per diluted share a year ago. Based on the company's strong year-to-date operating results, the company raised the lower end of adjusted EBITDA guidance to be in the range of $183 million to $195 million and adjusted income attributable to Gentiva shareholders to be in the range of $0.95 to $1.15 on a diluted per share basis. The company now expects full-year 2014 net revenues to be in the range of $1.96 billion to $2.0 billion. The company's 2014 outlook includes the full-year impact of its Harden acquisition and the final 2014 Medicare home health and hospice reimbursement rates issued by the Centers for Medicare and Medicaid Services (CMS).

Gentiva Health Services Inc., Q2 2014 Earnings Call, Aug 05, 2014

Gentiva Health Services Inc., Q2 2014 Earnings Call, Aug 05, 2014

Gentiva Health Services Inc. Provides Earnings Guidance for the Second Quarter Ended June 30, 2014; Reaffirms Earnings Guidance for the Full Year 2014

Gentiva Health Services Inc. provided earnings guidance for the second quarter ended June 30, 2014. For the quarter, the company anticipates net revenues of $496 million, adjusted EBITDA of $52 million, and adjusted income attributable to the company stockholders on a diluted basis of $0.33 per share. The company reaffirmed its full-year 2014 outlook. Net revenues are expected to be in the range of $1.9 billion to $2.1 billion, adjusted EBITDA is expected to be in the range of $177 million to $195 million, and adjusted income attributable to the company stockholders is expected to be in the range of $0.85 to $1.15 on a diluted per share basis.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
GTIV:US $19.47 USD +0.05

GTIV Competitors

Market data is delayed at least 15 minutes.

Company Last Change
BioScrip Inc $5.99 USD +0.15
Chemed Corp $103.34 USD +1.03
Civitas Solutions Inc $15.64 USD +0.77
Five Star Quality Care Inc $4.05 USD +0.06
Providence Service Corp/The $40.10 USD -0.64
View Industry Companies
 

Industry Analysis

GTIV

Industry Average

Valuation GTIV Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 0.4x
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales NM Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact GENTIVA HEALTH SERVICES, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.